Increase in AD*, CBS*, PSP, MSA-C, SD, bvFTD, ALS, CJD, TBI, cerebral infraction, progressive multifocal leukoencephalopathy, multiple sclerosis, ischemic stroke, glioma associated with gliosis. This evidence concerns the gene CBS and Alzheimer disease.